| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |